Target intelligence / Profile preview

Ras-related protein Rab-42 (RAB42)

Target
RAB42
Molecular classification
Small GTPase, Ras superfamily, Vesicular trafficking protein, Other
01

Overview

Ras-related protein Rab-42 (RAB42) is a small GTPase of the Ras oncogene family, involved primarily in the regulation of intracellular vesicular trafficking between endosomes and the trans-Golgi network[1][4]. RAB42 acts as a negative regulator of TLR9 and TLR4 signaling pathways, affecting immune responses in macrophages, and is implicated in modulating NF-κB/STAT3 signaling in megakaryocytic differentiation[1]. RAB42 is significantly overexpressed in a wide array of tumors, particularly in advanced cancers, and its high expression is associated with reduced immune cell infiltration, immune checkpoint gene expression, chemotherapy resistance, and poor overall survival. In hepatocellular carcinoma and glioma, RAB42 promotes cell proliferation, migration, and invasion[1][3]. It is considered a novel oncogenic driver, prognostic marker, and potential therapeutic target, especially in liver and brain cancers[1][2][3].

Other names
RAB42Ras-related protein Rab-42MGC45806member RAS oncogene familymember RAS homolog familyputative Ras-related protein Rab-42
02

Biological functions

Regulation of intracellular vesicular trafficking (endosome to trans-Golgi network)Signal transductionRegulation of immune responses (negative regulation of TLR9/TLR4 signaling)Cell proliferationCell migrationCell invasionRegulation of gene expression via RNA modificationOther
03

Disease associations

Cancer (driver and prognostic marker in hepatocellular carcinoma, glioma, and other cancers)Immune microenvironment modulationOther
04

Safety considerations

Functional redundancy with other Rab GTPases may complicate targeting[1]Role in fundamental cellular functions (vesicular trafficking, immune regulation) may raise off-target or toxicity concerns if inhibited[1]
05

Biomarkers

Prognostic biomarker for hepatocellular carcinoma (HCC)Diagnostic biomarker for pan-cancer settingsBiomarker for chemotherapy resistance in certain settingsMarker for poor immunotherapy response

Beyond the preview

Go deeper on Ras-related protein Rab-42 (RAB42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related protein Rab-42 (RAB42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call